Ilva D. Rupenthal

Jun 24, 2024 | mdpi.com | Ilva D. Rupenthal |Rinki Murphy |Odunayo O. Mugisho |Charisse Y. J

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 7, 2023 | mdpi.com | Ilva D. Rupenthal |Rinki Murphy |Charisse Y.-J. Kuo

1. IntroductionDiabetic retinopathy (DR) is a common cause of vision loss in patients with diabetes, affecting approximately 22.27% (103.12 million) of the global diabetic population in 2020. This number is expected to increase further, reaching 160.5 million by 2024 [].

Jul 18, 2023 | mdpi.com | Avik Shome |Odunayo O. Mugisho |Rachael L. Niederer |Ilva D. Rupenthal

Open AccessArticlebyAvik Shome 1, Odunayo O. Mugisho 1, Rachael L. Niederer 2,3 and Ilva D. Rupenthal 1,* 1Buchanan Ocular Therapeutics Unit, Department of Ophthalmology, The New Zealand National Eye Centre, University of Auckland, Auckland 1142, New Zealand2Department of Ophthalmology, The New Zealand National Eye Centre, University of Auckland, Auckland 1142, New Zealand3Te Whatu Ora Te Toka Tumai, Auckland 1142, New Zealand*Author to whom correspondence should be addressed.